Exploring various cyclization strategies, using a submicromolar pyrazole HTS screening hit 6 as a starting point, a novel indazole based CCR1 antagonist core was discovered. This report presents the design and SAR of CCR1 indazole and azaindazole antagonists leading to the identification of three development compounds, including 19e that was advanced to early clinical trials.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2018.12.024 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Myeloid-Derived Suppressor Cell Accumulation Drives Intestinal Fibrosis through mCCL6/hCCL15 Chemokine-Mediated Fibroblast Activation.
Adv Sci (Weinh)
December 2024
State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, 210023, China.
Intestinal fibrosis, a severe complication of Crohn's disease (CD), is linked to chronic inflammation, but the precise mechanism by which immune-driven intestinal inflammation leads to fibrosis development is not fully understood. This study investigates the role of myeloid-derived suppressor cells (MDSCs) in intestinal fibrosis in CD patients and a 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced mouse model. Elevated MDSCs are observed in inflamed intestinal tissues prior to fibrosis and their sustained presence in fibrotic tissues of both CD patients and murine models.
View Article and Find Full Text PDFCCR1 antagonist as a potential modulator of inflammatory, autophagic, and apoptotic markers in spinal cord injury.
Neuropharmacology
February 2025
Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D'Alcontres, 31, 98166, Messina, Italy.
Spinal cord injury (SCI) leads to severe and lasting impairments in motor and sensory functions. The intense inflammatory response following SCI is a significant challenge, and autophagy has emerged as a key factor in the recovery process. The C-C chemokine receptor type 1 (CCR1), a G-protein coupled receptor, plays a crucial role in managing the chemokine response under stress.
View Article and Find Full Text PDFIdentification and interaction mechanism of novel small molecule antagonists targeting CC chemokine receptor 1/3/5 for treatment of non-small cell lung cancer.
Mol Divers
November 2024
Chongqing College of Traditional Chinese Medicine, Chongqing, 402760, China.
Article Synopsis
- * CCR1, CCR3, and CCR5 are receptors that enhance NSCLC cells' migration and invasion, making them potential targets for therapy.
- * This research identified compound 5 as an effective inhibitor of NSCLC cell migration and invasion by binding to these receptors and suppressing key molecular pathways, offering insights for developing new drugs.
Inflammatory Role of CCR1 in the Central Nervous System.
Neuroimmunomodulation
September 2024
Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.
Background: Chemokine ligands and their corresponding receptors are essential for regulating inflammatory responses. Chemokine receptors can stimulate immune activation or inhibit/promote signaling pathways by binding to specific chemokine ligands. Among these receptors, CC chemokine receptor 1 (CCR1) is extensively studied as a G protein-linked receptor target, predominantly expressed in various leukocytes, and is considered a promising target for anti-inflammatory therapy.
View Article and Find Full Text PDFCCL16 is a pro-tumor chemokine that recruits monocytes and macrophages to promote hepatocellular carcinoma progression.
Am J Cancer Res
July 2024
Liver Research Center, Chang Gung Memorial Hospital Linkou, Taoyuan 333, Taiwan.
Article Synopsis
- Scientists are studying how a protein called CCL16 affects liver cancer (HCC) and found that high levels of it can lead to worse outcomes for patients.
- In lab tests, they saw that CCL16 makes cancer cells grow faster and helps recruit certain immune cells to the tumors.
- Their research suggests that blocking CCL16 could be a new way to treat liver cancer by stopping it from helping tumors grow.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!